Reproductive performance of Holstein-Friesian dairy cows subjected to different treatments for cystic ovarian follicles [electronic reource].

By: Contributor(s): Language: English Summary language: Arabic Description: p. 16-23Uniform titles:
  • Alexandria journal of veterinary science, 2017 v. 53 (2) [electronic reource].
Subject(s): Online resources: In: Alexandria Journal of Veterinary Science 2017.v.53(2)Summary: Cystic ovarian follicles “COF” is a common ovarian disorder diagnosed in dairy cattle that cause significant economic losses in dairy industry. This study was designed to evaluate efficacy of different therapeutic protocols of COF without determining cyst type. The study was conducted on 104 Holstein-Friesian cystic cows that were divided randomly to the following treatments: Experiment Ι: 1) Group G, n=27, subdivided into A) n=13: treated with 20μg Buserelin-GnRH agonist and B) n=14: treated with 100μg GonadorelinGnRH agonist; 2) Group GP, n=23: received 20μg Buserelin on day 0- 500μg of PGF2α on day 10; 3) Group GGP, n=27: received 2 doses of 20μg Buserelin 7 ds apart followed by 500μg PGF2α 7ds from the 2nd Buserelin injection; 4) Group GPG (Ovsynch), n=17: received 20μg Buserelin on day 0- 500μg PGF2α on day 7, and 48hrs later, 20μg Buserelin was injected; 5) Group C, n=10: no treatment received. 22 normal cycling cows were kept as a normal control-NC. Experiment ΙΙ: This part of the study was conducted on 34 cystic animals that did not respond to one of the previous treatments in experiment Ι and were divided into 2 groups: 1) Group CGP, n=19: CIDR+100μg Gonadorelin- (d 0), then 500μg of PGF2α on day 7, insert was removed on day 9; 2) Group PI, n=15: treated by oral administration of 5gm Potassium iodide dissolved in 500 ml sterile water for 7 successive days. Treated Cows were observed for 35 days from the end of treatment, females exhibited estrus were inseminated within 12 hours of detected heat. Pregnancy was confirmed by per rectum on day 50 post-insemination. Results showed that GP protocol achieved highest (P<0.05) estrus induction rate (EIR) recorded at 87%, followed by 70% for G and GGP group, and lowest (53%) obtained in GPG treated cows. Conception rate at 1st estrus and total conception rate (3 cycles after treatment) did not differ significantly among treatment groups, while pregnancy rates (PR) were significantly different (P<0.05) with highest (65.21%) obtained in GP protocol. Other groups recorded 63%, 55.55%, and 41.17% PR for G, GGP, and GPG respectively. In experiment ΙΙ, EIR was 47.36% and 33.33% for CGP and PI respectively with no significant difference, all conceived after 3 estrous cycles by the end of the experiment. In conclusion, GnRH+ PGF2α 10ds later was the most suitable treatment of COF regardless of cyst type, GGP protocol might be a profitable alternative to Ovsynch for treatment of cystic ovaries. Persistent cases of COF could be recruited to avoid culling for other treatment options such as CIDR or Potassium iodide with equal therapeutic efficacy.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode
Articles Articles Main ART AJVS V53 No2 3 (Browse shelf(Opens below)) Available

Includes references.

Cystic ovarian follicles “COF” is a common ovarian disorder diagnosed in dairy cattle that cause significant economic losses in dairy industry. This study was designed to evaluate efficacy of different therapeutic protocols of COF without determining cyst type. The study was conducted on 104 Holstein-Friesian cystic cows that were divided randomly to the following treatments: Experiment Ι: 1) Group G, n=27, subdivided into A) n=13: treated with 20μg Buserelin-GnRH agonist and B) n=14: treated with 100μg GonadorelinGnRH agonist; 2) Group GP, n=23: received 20μg Buserelin on day 0- 500μg of PGF2α on day 10; 3) Group GGP, n=27: received 2 doses of 20μg Buserelin 7 ds apart followed by 500μg PGF2α 7ds from the 2nd Buserelin injection; 4) Group GPG (Ovsynch), n=17: received 20μg Buserelin on day 0- 500μg PGF2α on day 7, and 48hrs later, 20μg Buserelin was injected; 5) Group C, n=10: no treatment received. 22 normal cycling cows were kept as a normal control-NC. Experiment ΙΙ: This part of the study was conducted on 34 cystic animals that did not respond to one of the previous treatments in experiment Ι and were divided into 2 groups: 1) Group CGP, n=19: CIDR+100μg Gonadorelin- (d 0), then 500μg of PGF2α on day 7, insert was removed on day 9; 2) Group PI, n=15: treated by oral administration of 5gm Potassium iodide dissolved in 500 ml sterile water for 7 successive days. Treated Cows were observed for 35 days from the end of treatment, females exhibited estrus were inseminated within 12 hours of detected heat. Pregnancy was confirmed by per rectum on day 50 post-insemination. Results showed that GP protocol achieved highest (P<0.05) estrus induction rate (EIR) recorded at 87%, followed by 70% for G and GGP group, and lowest (53%) obtained in GPG treated cows. Conception rate at 1st estrus and total conception rate (3 cycles after treatment) did not differ significantly among treatment groups, while pregnancy rates (PR) were significantly different (P<0.05) with highest (65.21%) obtained in GP protocol. Other groups recorded 63%, 55.55%, and 41.17% PR for G, GGP, and GPG respectively. In experiment ΙΙ, EIR was 47.36% and 33.33% for CGP and PI respectively with no significant difference, all conceived after 3 estrous cycles by the end of the experiment. In conclusion, GnRH+ PGF2α 10ds later was the most suitable treatment of COF regardless of cyst type, GGP protocol might be a profitable alternative to Ovsynch for treatment of cystic ovaries. Persistent cases of COF could be recruited to avoid culling for other treatment options such as CIDR or Potassium iodide with equal therapeutic efficacy.

Summary in Arabic

There are no comments on this title.

to post a comment.

Home | About ENAL | Collections | Services | Activities | Calendar | Contact us

7 Nadi El Sayed St., Giza, Egypt | Phone:02-33351121 +02-33351313 | 
| Email: enalegypt@gmail.com